WO2017201596A1 - Composição cosmética antissinais, sistema de composições e método para tratamento cosmético da pele - Google Patents
Composição cosmética antissinais, sistema de composições e método para tratamento cosmético da pele Download PDFInfo
- Publication number
- WO2017201596A1 WO2017201596A1 PCT/BR2017/050127 BR2017050127W WO2017201596A1 WO 2017201596 A1 WO2017201596 A1 WO 2017201596A1 BR 2017050127 W BR2017050127 W BR 2017050127W WO 2017201596 A1 WO2017201596 A1 WO 2017201596A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- composition
- days
- composition according
- mixtures
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 273
- 239000002537 cosmetic Substances 0.000 title claims abstract description 61
- 238000011282 treatment Methods 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title claims description 33
- 230000001153 anti-wrinkle effect Effects 0.000 title abstract 2
- 230000001953 sensory effect Effects 0.000 claims abstract description 18
- 239000007764 o/w emulsion Substances 0.000 claims abstract description 6
- 210000000245 forearm Anatomy 0.000 claims description 53
- 239000000284 extract Substances 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 239000003607 modifier Substances 0.000 claims description 10
- 239000003963 antioxidant agent Substances 0.000 claims description 8
- 235000014121 butter Nutrition 0.000 claims description 8
- 244000299461 Theobroma cacao Species 0.000 claims description 7
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 7
- 230000003078 antioxidant effect Effects 0.000 claims description 7
- 239000003906 humectant Substances 0.000 claims description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000003974 emollient agent Substances 0.000 claims description 6
- 230000000475 sunscreen effect Effects 0.000 claims description 6
- 239000000516 sunscreening agent Substances 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 239000004322 Butylated hydroxytoluene Substances 0.000 claims description 4
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 4
- 241000169624 Casearia sylvestris Species 0.000 claims description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical group C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 244000269722 Thea sinensis Species 0.000 claims description 4
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 4
- 229940095259 butylated hydroxytoluene Drugs 0.000 claims description 4
- 229940008099 dimethicone Drugs 0.000 claims description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 4
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000036560 skin regeneration Effects 0.000 claims description 4
- 230000004936 stimulating effect Effects 0.000 claims description 4
- 230000000699 topical effect Effects 0.000 claims description 4
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 3
- 244000298479 Cichorium intybus Species 0.000 claims description 3
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 3
- 244000236658 Paeonia lactiflora Species 0.000 claims description 3
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 241000192248 [Candida] saitoana Species 0.000 claims description 3
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 3
- 229940024606 amino acid Drugs 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 229940036350 bisabolol Drugs 0.000 claims description 3
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 3
- 229960005323 phenoxyethanol Drugs 0.000 claims description 3
- 239000000419 plant extract Substances 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- ITIMHIATVYROGF-XWUOBKMESA-N (3S)-3-[[(2S)-2-acetamido-6-aminohexanoyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid Chemical compound CC(C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O ITIMHIATVYROGF-XWUOBKMESA-N 0.000 claims description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 claims description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 2
- 241000454552 Astrocaryum murumuru Species 0.000 claims description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 claims description 2
- 240000008375 Hymenaea courbaril Species 0.000 claims description 2
- 235000014020 Hymenaea courbaril Nutrition 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 2
- 229920000299 Nylon 12 Polymers 0.000 claims description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 claims description 2
- 244000288157 Passiflora edulis Species 0.000 claims description 2
- 235000000370 Passiflora edulis Nutrition 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- 108010077895 Sarcosine Proteins 0.000 claims description 2
- 244000099523 Schinus terebinthifolius Species 0.000 claims description 2
- 235000004120 Schinus terebinthifolius Nutrition 0.000 claims description 2
- 235000013474 Spilanthes acmella Nutrition 0.000 claims description 2
- 244000139010 Spilanthes oleracea Species 0.000 claims description 2
- 235000007892 Spilanthes oleracea Nutrition 0.000 claims description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 2
- 235000006468 Thea sinensis Nutrition 0.000 claims description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 2
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 claims description 2
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 claims description 2
- 229960003055 bisoctrizole Drugs 0.000 claims description 2
- 229940106189 ceramide Drugs 0.000 claims description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 2
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 229940100539 dibutyl adipate Drugs 0.000 claims description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 claims description 2
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 claims description 2
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 2
- YKZPPPNXRZHVGX-PXYKVGKMSA-L dipotassium;(2s)-2-aminobutanedioate;hydron;hydrate Chemical compound [H+].[H+].O.[K+].[K+].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O YKZPPPNXRZHVGX-PXYKVGKMSA-L 0.000 claims description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 2
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- 150000002334 glycols Chemical class 0.000 claims description 2
- 235000009569 green tea Nutrition 0.000 claims description 2
- 229960004881 homosalate Drugs 0.000 claims description 2
- 229940039346 isoamyl cocoate Drugs 0.000 claims description 2
- CRSJYWPXKKSOCQ-CBAPHJFVSA-L magnesium;(2s)-2-aminobutanedioate;hydron;tetrahydrate Chemical compound O.O.O.O.[Mg+2].[O-]C(=O)[C@@H](N)CC(O)=O.[O-]C(=O)[C@@H](N)CC(O)=O CRSJYWPXKKSOCQ-CBAPHJFVSA-L 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 2
- 229960001679 octinoxate Drugs 0.000 claims description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 2
- 229940113124 polysorbate 60 Drugs 0.000 claims description 2
- 229940068988 potassium aspartate Drugs 0.000 claims description 2
- 229940111263 potassium magnesium aspartate Drugs 0.000 claims description 2
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 2
- 229940043230 sarcosine Drugs 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 229940031439 squalene Drugs 0.000 claims description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 2
- 150000005846 sugar alcohols Chemical class 0.000 claims description 2
- 239000010936 titanium Substances 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims 2
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims 1
- LHWUVOILCRBENG-UHFFFAOYSA-N 7-methyloctyl 7-methyloctanoate Chemical compound CC(C)CCCCCCOC(=O)CCCCCC(C)C LHWUVOILCRBENG-UHFFFAOYSA-N 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 229940100524 ethylhexylglycerin Drugs 0.000 claims 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 claims 1
- 239000006071 cream Substances 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000000295 complement effect Effects 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 136
- 230000037303 wrinkles Effects 0.000 description 52
- 238000011156 evaluation Methods 0.000 description 50
- 238000005259 measurement Methods 0.000 description 50
- 230000009467 reduction Effects 0.000 description 44
- 230000008591 skin barrier function Effects 0.000 description 40
- 238000011160 research Methods 0.000 description 31
- 230000000694 effects Effects 0.000 description 30
- 230000006872 improvement Effects 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 230000001815 facial effect Effects 0.000 description 20
- 230000037067 skin hydration Effects 0.000 description 17
- 230000037394 skin elasticity Effects 0.000 description 16
- 230000037393 skin firmness Effects 0.000 description 16
- 230000036571 hydration Effects 0.000 description 14
- 238000006703 hydration reaction Methods 0.000 description 14
- 230000036548 skin texture Effects 0.000 description 12
- 230000007246 mechanism Effects 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 230000008569 process Effects 0.000 description 9
- 102000008186 Collagen Human genes 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 230000008288 physiological mechanism Effects 0.000 description 8
- 239000002243 precursor Substances 0.000 description 8
- 230000000670 limiting effect Effects 0.000 description 7
- 230000032683 aging Effects 0.000 description 6
- 230000004888 barrier function Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 230000036572 transepidermal water loss Effects 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 230000037075 skin appearance Effects 0.000 description 4
- 230000036555 skin type Effects 0.000 description 4
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- 230000001010 compromised effect Effects 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000027288 circadian rhythm Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 239000008309 hydrophilic cream Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- 244000145321 Acmella oleracea Species 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 244000141804 Theobroma grandiflorum Species 0.000 description 1
- 235000002424 Theobroma grandiflorum Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000004900 autophagic degradation Effects 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000009442 healing mechanism Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- -1 polymethylsiloxane Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037070 skin defense Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention is directed to cream gel texture antisignal cosmetic compositions in the form of oil-in-water emulsion comprising sensory ingredients suitable for complete skin treatment, also having specific benefits that complement each other day and night.
- rhythms associated with its duration time, among them the circadian rhythm, cycles that complete every 24 hours.
- the skin does not "perceive" light variations, but is subject to environmental agents such as temperature, humidity, mechanical and biological agents.
- Skin temperature skin temperature varies according to the measured location; the temperature of the forearm skin is maximum in the late afternoon, while in the face it reaches its maximum in the morning; at night the skin temperature is lower.
- the effect of a treatment may vary and be dependent on the time of its administration.
- Factors such as absorption, metabolism, storage, and affinity of a compound for cell receptors may vary according to circadian rhythms.
- the present invention relates to antisignal cosmetic compositions in the form of an oil-in-water emulsion comprising:
- Another object of the present invention is a composition system comprising a composition for daytime application and a composition for nighttime application.
- a further object is a cosmetic method of treating the skin comprising applying the composition of the present invention.
- Figure 1 graphs the averages of variation in transsepidermal skin water loss obtained at baseline and after 7, 14, and 28 days of use of compositions (30+) according to example 1 (day) , in relation to control.
- Figure 2 presents a graph of the averages of variation in transsepidermal skin water loss obtained at baseline and after 7, 14, and 28 days of use of compositions (30+) according to example 2 (night). , in relation to control.
- Figures 3 and 4 show the average improvement in testing performed as per example 8 of this descriptive report for (45+) night compositions.
- Figure 6 illustrates the mean values of the Ur / Uf parameter obtained in the facial and forearm region at baseline and after 28 days of home use for day (45+) compositions.
- Figure 10 shows hydration kinetics conferred by the product (45+) according to the present invention with respect to the control.
- Figure 1 1 shows kinetics of the percentage of hydration conferred by composition (45+) relative to control.
- Figures 12 and 13 show the percent improvement in antisignal efficacy assessment of antisignal (60+) cosmetic compositions according to the present invention turned to the day by instrumental measurements under normal conditions of use.
- Figures 14 and 15 show the percent improvement in the antisignal efficacy evaluation of antisignal (60+) cosmetic compositions according to the present invention turned at night by instrumental measurements under normal conditions of use.
- Figure 16 shows the means of variation in transepidermal skin water loss obtained at baseline and after 7, 14, and 28 days of use.
- Figures 17 and 18 show the percent improvement in antisignal efficacy evaluation of antisignal (70+) cosmetic compositions of the present invention geared to the day by instrumental measurements under normal conditions of use.
- Figures 19 and 20 show the percent improvement in antisignal efficacy evaluation of antisignal (70+) cosmetic compositions according to the present invention turned to the night by instrumental measurements under normal conditions of use.
- the present invention is concerned with antisignal, cream gel texture cosmetic compositions, in the form of oil-in-water emulsion, capable of treating the six major physiological mechanisms of the skin simultaneously, bringing extended benefits with progressive results during treatment.
- the six major physiological mechanisms according to the present invention include:
- Skin means skin of the neck, face, arm, forearm, lap and hands.
- antisignal cosmetic compositions are meant cosmetic compositions suitable for use in various age groups.
- the age groups comprise ages above 30 years, particularly above 45 years, over 60 years and over 70 years.
- compositions specific to different age groups will be cited as: compositions (30+), referring to ages above 30 years; compositions (45+) relating to ages over 45 years; compositions (60+) relating to ages over 60 years; and compositions (75+), referring to ages over 60 years.
- Another object of the present invention is a system of antisignal cosmetic compositions, which are complementary for day and night use, which have suitable active ingredients for each period.
- Suitable ingredients for each period in the present invention are sunscreens / sunscreens, antioxidant actives with prolonged hydration for the day, and actives for stimulating skin regeneration by eliminating toxins and deep night nutrition.
- Still another object of the invention is to provide antisignal cosmetic compositions having a cream gel texture, the application of which has ease of spreading on the skin, forming an emollient and moisturizing film, without leaving the appearance shiny and oily.
- the cream gel texture and its qualities according to the present invention are obtained through the use of low and medium molecular weight emollient esters with high concentration of volatile emollients, which evaporate rapidly during application giving greater spreadability and rapid absorption. .
- the present invention relates to cream gel texture antisignal cosmetic compositions, in the form of an oil-in-water emulsion, comprising at least one emollient, at least one antioxidant, at least one humectant, at least one active compound, at least 100%. one less emulsifier, at least one sensory modifier and cosmetically acceptable vehicles.
- Another object of the present invention is a method for cosmetic skin treatment comprising topically applying a composition of the present invention to the skin to be treated, wherein the application occurs during the day and / or at night.
- compositions of the present invention comprise in particular:
- Emollients may be selected from caprylyl methicone, C12-15 alkyl benzoate, dibutyl adipate, dicaprylyl carbonate, isononyl isononanoate, dicapryl ether, dodecane, ethylhexyl palmitate, ethyl macadamiaecate, isohexadicide, isohexadicide. / caprylic, butters of Brazilian biodiversity, isoamyl cocoate or mixtures thereof.
- the following Brazilian biodiversity butters may be used, without limiting the scope of the present invention: murumuru butter which aids in lipid replacement of the skin barrier, providing repair and protection, resulting in decreased water loss and maintenance of hydration natural skin;
- Other butters such as those obtained from cocoa (Theobroma cacao), cupuaçu (Theobroma grandiflorum), ucu ⁇ ba and sapucainha seeds, or mixtures thereof.
- Butters aid in lipid replacement of the skin barrier, providing repair and protection, which helps to decrease water loss and maintain the skin's natural hydration longer.
- Antioxidants without limiting the scope of the present invention may be selected from butylated hydroxytoluene (BHT), tocopherol acetate or Natural plant extracts, eg Camellia sinensis (green tea), Theobroma cacao (cocoa), Spilanthes acmella (Jambu) or mixtures thereof.
- BHT butylated hydroxytoluene
- Natural plant extracts eg Camellia sinensis (green tea), Theobroma cacao (cocoa), Spilanthes acmella (Jambu) or mixtures thereof.
- the polyphenols contained in green tea extract mainly have the ability to interact with cell membranes and protect cells from oxidative processes, thereby ensuring the proper functioning and protection of cell energy, also promoting cell renewal.
- Humectants may be selected from sugar alcohols such as glycols, glycerol, sorbitol, mannitol or mixtures thereof.
- the humectant is vegetable glycerin, extracted from palm oil, which aids in surface hydration. This effect combined with the protection provided by the butters promotes the recovery of the skin's natural moisture barrier.
- the active compound of the present invention may be selected from peptides which are generally synthetic molecules, particularly acetyl tetrapeptide-2, which acts to stimulate collagen and elastin production, thereby promoting the improvement of skin tone and elasticity.
- the active compound may also be selected from Hymenaea courbaril extract; a mixture of sodium cocoyl amino acids / sarcosine / potassium aspartate / magnesium aspartate / propylene glycol; a mixture of Paeonia albiflora / phenoxyethanol / ethylhexylglycerine extract; Cichorium intybus extract; Schinus Terebinthifolius leaf extract; omega 6 passion fruit ceramide; or mixtures thereof.
- Emulsifiers may be selected from at least one of glyceryl stearate citrate, potassium cetyl phosphate, PEG-100, acrylates, xanthan gum, cetearyl alcohol, glyceryl stearate / PEG-100 mixture. others known in the prior art, or mixtures thereof.
- Sensory modifiers may be selected from silicones such as cyclopentasiloxane, dimethicone or cyclopentasiloxane / dimethicone crospolymers, or among other compounds such as titanium isopropyl triisostearate, nylon-12, polymethylsiloxane, aluminum starch octenyl succinate or mixtures thereof.
- silicones such as cyclopentasiloxane, dimethicone or cyclopentasiloxane / dimethicone crospolymers, or among other compounds such as titanium isopropyl triisostearate, nylon-12, polymethylsiloxane, aluminum starch octenyl succinate or mixtures thereof.
- compositions according to the present invention may further comprise a viscosity donor selected from C 10-30 alkyl acrylate acrylate crospolymer, carbopol, such as Carbopol ETD 2020, hydroxyethyl acrylate / sodium acryloyl dimethyltaurate copolymer mixture, squalene and polysorbate 60 (Simulgel NS), or mixtures thereof.
- a viscosity donor selected from C 10-30 alkyl acrylate acrylate crospolymer, carbopol, such as Carbopol ETD 2020, hydroxyethyl acrylate / sodium acryloyl dimethyltaurate copolymer mixture, squalene and polysorbate 60 (Simulgel NS), or mixtures thereof.
- Cosmetically acceptable vehicles may be selected from the compounds known in the art.
- vehicles include: preservatives, perfumes / fragrances, polymer neutralizers, chelating agents, pH adjusters, among others.
- Particularly disodium EDTA (chelating agent), iodopropynyl butyl carbamate (preservative), phenoxyethanol (preservative), paddle essential oil (perfume) and triethanolamine (pH adjuster) are used.
- Sunscreens may be selected from bemotrizinola (bis-ethylhexyloxyphenol methoxyphenyl triazine), diethylamino hydroxybenzoylhexyl benzoate, ethylhexyl methoxycinnamate, homosalate, bisoctrizole (TINOSORB Myls triazine).
- bemotrizinola bis-ethylhexyloxyphenol methoxyphenyl triazine
- diethylamino hydroxybenzoylhexyl benzoate diethylamino hydroxybenzoylhexyl benzoate
- ethylhexyl methoxycinnamate ethylhexyl methoxycinnamate
- homosalate bisoctrizole (TINOSORB Myls triazine).
- Assets for stimulating skin regeneration by elimination of toxins in the present invention pertain to Candida saitoana extract; bisabolol; Casearia sylvestris leaf extract, and Casearia sylvestris / silica mixture or mixtures thereof.
- Candida saitoana extract stimulates cellular detoxification mechanisms through cellular autophagy, reducing the accumulation of cell toxins.
- Bisabolol which may also be included in the composition, acts on the mechanisms of dermal and epidermal damage by regulating the production of IL-6 and IL-8 microdamage agents.
- antisignal cosmetic compositions according to the present invention, which surprisingly act simultaneously on the six major physiological mechanisms of the skin, promoting deep nutrition, allied to the antioxidant and toxin-eliminating effect, particularly when used as a system of complementary compositions for day and night use.
- Daytime use cosmetic compositions have been produced in the form of oil-in-water cream gel emulsions in which oil is the dispersed phase and water is the continuous phase. Both phases were heated to a temperature of 75-80 ⁇ ° C, then pouring the oil phase, where the sunscreens are, into the aqueous phase under stirring for about 10 minutes. Subsequently, the cooling phase of the process was started, with the addition of an aqueous phase with polymer neutralizer. When the temperature reached about 60 ° C, the appendage of the sensory modifiers (silicones) was added and when the temperature reached 40 ° C, the preservatives, fragrance, sensory modifiers (particles) and the sensitive actives were added. high temperatures.
- Cosmetic compositions intended for night use were produced in the form of oil-in-water cream gel emulsions, in which the oil is the dispersed phase and water is the continuous phase.
- heating of the aqueous phase was started in the main vessel to a temperature of about 75 ° C to about 80 ° C and, under stirring, the oil phase was added under stirring for about 10 minutes.
- the cooling phase of the process was started, with the addition of an aqueous phase with polymer neutralizer.
- the temperature reached about 60 ° C the phase of the sensory modifiers (silicones) was added and when the temperature reached about 40 ° C, the preservatives, fragrance, sensory modifiers (particles) and the actives were added. sensitive to high temperatures.
- compositions according to example 1 of the present invention were found to keep the skin hydrated for up to 24 hours compared to the control (skin without application of any products).
- Application of the compositions according to example 1 of the present invention increased the skin hydration level by up to 62%. All participants showed improvement in skin hydration.
- Example 4 Evaluation of antisignal efficacy of compositions (30+) for daytime use by instrumental measurements under normal use conditions A study was conducted to verify the effectiveness of the formulations of Example 1 according to the present invention in reducing wrinkles and improving skin texture.
- compositions according to example 1 of the present invention promoted the reduction of the wrinkle volume, the reduction of the average wrinkle depth and the reduction of the maximum wrinkle after fourteen days of use.
- Example 5 Evaluation of antisignal efficacy of cosmetic compositions (30+) for overnight use by instrumental measurements under normal conditions of use.
- compositions evaluated are in accordance with example 2 of the present invention, the methodology employed is the same as that of example 4, except that the measurements were made during the initial date, after 14 days, after 28 days and after 56 days.
- the methodology consisted of evaluating the transepidermal loss of water from the skin after a partial removal of the horny extract. Measurements were collected at baseline and after 7, 14 and 28 days of use of the compositions according to example 1 of the present invention.
- E trans epidermal water loss
- ET30 TEWL value after 30 stratum corneum layer removals.
- ET0 TEWL value measured on intact skin;
- X control or formulation used.
- Example 7 Evaluation of the skin barrier fortifying effect provided by the use of compositions (30+) for overnight use.
- Example 8 Evaluation of antisignal efficacy of a cosmetic product (45+) at night by instrumental measurements under normal use conditions
- the aim of the study was to verify the efficacy of compositions according to the present invention in reducing wrinkles and improving skin texture when applied once daily by instrumental evaluations after 14 ⁇ 2 days, 28 ⁇ 2 days. and 56 ⁇ 2 days of use.
- compositions according to the present invention in reducing the signs of facial aging such as wrinkles and sagging was evaluated by clinical and subjective evaluations performed on 69 volunteers who applied the compositions once daily to the face. and neck evenly after cleansing the skin.
- the study was a unicenter, non-comparative, nonrandomized study aimed at evaluating the clinical efficacy in reducing the signs of facial aging of a cosmetic product evaluated at the indicated site according to mode of use for 28 days. Clinical evaluations were performed at Visits: Visit 01 / D-7, Visit 02 / DO, Visit 03 / D07, Visit 04 / D14, Visit 05 / D28 and Visit 06 / D56 after 56 days of using the compositions.
- compositions according to the present invention provided improved facial contour at all times evaluated, being statistically significant (p ⁇ 0.05) at D56 when compared to the initial DO time;
- compositions according to the present invention provided an improvement in healthy skin appearance of the volunteers at all times evaluated and were also statistically significant (p 0.05) when compared to the initial OD time;
- compositions according to the present invention provided an improvement in the overall skin appearance of the volunteers at all times evaluated, being statistically significant (p ⁇ 0.05) at D14 and D56 when compared to the initial DO time;
- compositions according to the present invention in the efficacy of reducing facial aging signs such as wrinkles and sagging was evaluated by clinical and subjective evaluations in 72 volunteers who used the composition daily by face application. overnight evenly after cleansing the skin.
- the study was a unicentric, non-comparative, nonrandomized study aimed at evaluating the clinical efficacy in reducing the signs of facial aging of the product evaluated at the indicated location according to mode of use for 28 days. Clinical evaluations were performed at Visits: Visit 01 / D-7, Visit 02 / DO, Visit 03 / D07, Visit 04 / D14, Visit 05 / D28 and Visit 06 / D 56 after 56 days of use of the composition.
- compositions according to the present invention provided an improvement in the degree of periorbital wrinkles in D14, D28 and D56, but did not show statistically significant changes (p> 0.05);
- compositions according to the present invention provided improved facial contour at all times evaluated, being statistically significant (p ⁇ 0.05) at D56 when compared to the initial DO time;
- compositions according to the present invention provided an improvement in healthy skin appearance of volunteers at all times evaluated, being statistically significant (p ⁇ 0.05) at D14, D28 and D56 when compared to the initial DO time;
- compositions according to the present invention provided an improvement in the overall skin appearance of volunteers at all times evaluated and were also statistically significant (p 0.05) when compared to the initial OD time;
- Example 11 Evaluation of skin firmness and elasticity increase by cutometry for day (45+) compositions.
- the methodology consisted of evaluating the increase in skin firmness and elasticity through cutometric measurements (Cutometer® MPA-580 and Multiprobe Adapter MPA-580, CKeletronics, Germany) performed at baseline and after 28 days of use. investigated composition. Increased skin firmness was assessed using the Ur / Ue (R5) parameter and increased skin elasticity was assessed using the Ur / Uf (R7) parameter. Cutometry measurements were taken at the forearm region and at the outer corner of the eye.
- the Ur / Ue parameter is the ratio between immediate shrinkage and immediate skin deformation and corresponds to biological elasticity.
- % ARi percentage increase in firmness
- Ur / Urt0 mean values of the Ur / Ue parameter obtained at baseline.
- % AEti percentage increase in elasticity
- Ur / Uft0 mean values of the Ur / Uf parameter obtained at baseline.
- compositions according to the present invention provided an average 36.7% increase in facial skin firmness after 28 days of home use, relative to the initial skin condition.
- Figure 5 illustrates the mean values of the Ur / Ue parameter obtained in the facial and forearm region at baseline and after 28 days of home use of the compositions according to the present invention.
- Example 12 Evaluation of skin firmness and elasticity increase by cutometry for night (45+) compositions.
- compositions according to the present invention Increased skin firmness and elasticity after 28 days of home use of the compositions according to the present invention was evaluated.
- the methodology consisted of evaluating the increase in skin firmness and elasticity through cutometry measurements (Cutometer® MPA-580 and Multiprobe Adapter MPA-580, CKeletronics, Germany) performed at baseline and after 28 days of home use. of the composition investigated. Increased skin firmness was assessed using the Ur / Ue (R5) parameter and increased skin elasticity was assessed using the Ur / Uf (R7) parameter. Cutometry measurements were performed in the forearm region and in the outer corner of the eye, after applying the compositions according to present invention daily, once during the night on the face and forearm, evenly after cleansing the skin.
- the methodology consisted of assessing transsepidermal skin water loss following a partial removal of the horny extract at baseline and after 7, 14, and 28 days of use of the composition.
- a tape-stripping process was used, where 30 repetitions of application and removal of transparent medical tape (Transpore 3M, 3M, Brazil) were performed in demarcated sites on the forearm, followed by measuring transsepidermal water loss (Tewameter® 300 and Multiprobe Adapter MPA-5, CKeletronics, Germany).
- the forearms of composition and control application were randomized.
- compositions according to the present invention were applied sufficiently to the forearm demarcated with the satin ribbon tied at the wrist.
- the product was applied to the clean forearm once a day during free time.
- compositions according to the present invention applied to the skin of the volar forearm conferred significant skin barrier fortification effect when compared to the control after 7, 14 and 28 days of home use.
- the percentage value obtained from skin barrier fortification in relation to initial skin condition and control was 22.5% after 7 days, 32.2% after 14 days and 37.3% after 28 days of home use. 100.0% of the research participants presented skin barrier fortification after home use of the investigated composition.
- Capacitance measurements were performed using the Corneometer® 825 probe coupled to the Multi Probe Adapter equipment, MPA 5 (CKeletronics, Germany).
- an automated Microsoft® Office Excel 2010 software spreadsheet was used to calculate the Coefficient of Variation (CV) of the readings obtained.
- CV Coefficient of Variation
- a minimum of 5 and a maximum of 10 measurements per site were performed in each evaluation time. If in 5 measurements the CV had a value of less than 6%, the measurements on the site were closed. Otherwise, readings were continued until a CV of less than 6% was obtained, considering a maximum of 10 measurements. At the end of 10 measurements, not reaching CV ⁇ 6%, the value of 10% is considered as the new limit, closing the site readings or restarting the whole process if above 10%.
- the hydration of the skin provided by the application of a moisturizing product is evidenced by the increased capacitance value generated in the capacitor formed between the base of the Corneometer® probe and the skin.
- the higher the capacitance value the greater the amount of water in the skin and thus the higher its hydration level.
- Ah hti - htO (Equation 1) From the hydration difference (Ah) values were calculated the hydration parameters (H) and skin hydration percentage (% H) provided by the composition, according to Equations 2 and 3.
- Hti skin hydration after 1 hour of applying the composition
- Ahti (control) and Ahti (composition) skin hydration differences obtained for control and composition, respectively.
- Hti skin hydration provided by applying the composition within 1 hour of application
- Figures 10 and 11 show the average hydration values (Hti) and the percentage of skin hydration (% Hti) after application of the composition in relation to the control.
- compositions according to the present invention to the skin in the forearm region:
- Example 15 Sensory analysis by perceived efficacy after application of cosmetic compositions (60+) according to the present invention in day versions.
- the methodology consisted of sensory analysis for perceived efficacy through the application of a questionnaire answered by the research participants after 10 minutes of applying the composition.
- Example 16 Sensory analysis by perceived efficacy after application of the cosmetic compositions (60+) according to the present invention in the night versions.
- the methodology consisted of sensory analysis for perceived efficacy through the application of a questionnaire answered by the research participants after 10 minutes of applying the composition.
- Example 17 Evaluation of antisignal efficacy by instrumental measurements under normal conditions of use— compositions (60+) in the day version.
- the aim of the study was to verify the effectiveness of the compositions according to the present invention in reducing wrinkles and improving skin texture when applied under recommended conditions of use by instrumental evaluations after 14 ⁇ 2 days, 28 ⁇ 2 days and 56 ⁇ 2 days of use.
- composition tested promoted the reduction of wrinkle volume after twenty eight and fifty six days of use
- composition tested promoted the reduction of the average wrinkle roughness after fourteen, twenty eight and fifty six days of use;
- composition tested promoted the reduction of the average depth of wrinkles after fourteen, twenty eight and fifty six days of use;
- the tested composition promoted the reduction of maximum wrinkle roughness after fourteen, twenty-eight and fifty-six days of use;
- composition tested reduced skin dimple after twenty-eight and fifty-six days of use;
- composition tested promoted the reduction of wrinkle depth after twenty-eight and fifty-six days of use;
- composition tested improved skin texture after twenty-eight and fifty-six days of use.
- Example 18 Evaluation of antisignal efficacy by instrumental measurements under normal conditions of use— compositions (60+) in the night version.
- the aim of the study was to verify the effectiveness in reducing wrinkles and improving skin texture when applied under recommended conditions of use by instrumental evaluations after 14 ⁇ 2 days, 28 ⁇ 2 days and 56 ⁇ 2 days of use. .
- composition tested reduced the volume of wrinkles after fourteen and fifty-six days of use
- composition tested promoted the reduction of the average wrinkle roughness after fourteen, twenty eight and fifty six days of use;
- ⁇ The tested composition promoted the reduction of the average wrinkle depth after fourteen, twenty-eight and fifty-six days of use;
- composition tested promoted the reduction of the maximum wrinkle roughness after fourteen, twenty eight and fifty six days of use;
- composition tested promoted the reduction of skin curl after fourteen and fifty-six days of use
- composition tested promoted the reduction of wrinkle depth after fourteen and fifty-six days of use
- composition tested improved skin texture after twenty-eight days of use.
- Example 19 Evaluation of the skin barrier fortifying effect provided by the use of cosmetic product - composition (60+)
- the composition applied to the skin of the volar forearm conferred a significant skin barrier strengthening effect when compared to the control after 14 and 28 days of home use.
- the percentage value obtained from skin barrier fortification in relation to the initial skin condition and control was 16.0% and 19.3% after 14 and 28 days of home use, respectively. Eighty-one percent of the study participants had skin barrier fortification after home use of the investigated composition.
- AEDi transsepidermal skin water loss
- Example 20 Evaluation of antisignal efficacy of a cosmetic product by instrumental measurements under normal conditions of use - day-directed (70+) compositions
- the aim of the study was to verify the effectiveness of the compositions according to the present invention in reducing wrinkles and improving skin texture when applied under recommended conditions of use by instrumental evaluations after 14 ⁇ 2 days, 28 ⁇ 2 days and 56 ⁇ 2 days of use.
- compositions according to the present invention promoted reduction in the volume of wrinkles after fourteen, twenty eight and fifty six days of use;
- compositions according to the present invention have promoted the reduction of the average wrinkle roughness after fourteen, twenty eight and fifty six days of use;
- the compositions according to the present invention have promoted the reduction of the average wrinkle depth after fourteen, twenty eight and fifty six days of use;
- compositions according to the present invention have promoted the reduction of maximum wrinkle roughness after fourteen, twenty eight and fifty six days of use;
- compositions according to the present invention promoted reduction of skin curl after fourteen, twenty eight and fifty six days of use;
- compositions according to the present invention promoted reduction of wrinkle depth after fourteen, twenty-eight and fifty-six days of use.
- compositions according to the present invention promoted improvement of skin texture after fourteen, twenty eight and fifty six days of use.
- Example 21 Evaluation of antisignal efficacy of a cosmetic product by instrumental measurements under normal conditions of use - night time (70+) compositions
- the aim of the study was to verify the effectiveness in reducing wrinkles and improving skin texture when applied under recommended conditions of use by instrumental evaluations after 14 ⁇ 2 days, 28 ⁇ 2 days and 56 ⁇ 2 days of use. .
- composition according to the present invention promoted the reduction of wrinkle volume after fourteen and fifty six days of use
- composition according to the present invention promoted the reduction of the average wrinkle roughness after fourteen, twenty eight and fifty six days of use;
- composition according to the present invention promoted the reduction of the average depth of wrinkles after fourteen, twenty eight and fifty six days of use;
- composition according to the present invention promoted the reduction of maximum wrinkle roughness after fourteen, twenty eight and fifty six days of use;
- composition according to the present invention promoted the reduction of wrinkle curl after fourteen and fifty six days of use.
- composition according to the present invention promoted the reduction of wrinkle depth after fourteen and fifty six days of use.
- Example 22 Evaluation of the skin barrier fortifying effect provided by the compositions (70+) of the present invention - day-directed.
- the methodology consisted of evaluating the transepidermal loss of skin water after a partial removal of the horny extract at baseline and after 7, 14 and 28 days of use of the composition.
- a tape-stripping process was used, where 30 repetitions of application and removal of transparent medical tape (Transpore 3M, 3M, Brazil) were performed in demarcated sites on the forearm, followed by Transsepidermal Water Loss Measurement (Tewameter® 300 and Multiprobe Adapter MPA-5, CKeletronics, Germany).
- the forearms of composition and control application were randomized.
- the composition applied to the skin of the volar forearm, conferred significant skin barrier fortification effect when compared to the control after 7, 14 and 28 days of home use.
- the percentage value obtained from skin barrier fortification in relation to the initial skin condition and control was 14.5% after 7 days, 21.1% after 14 days and 25.0% after 28 days of home use. 88.0% of the research participants presented skin barrier fortification after home use of the investigated composition.
- Example 23 Evaluation of the skin barrier fortifying effect provided by the use of cosmetic product - night-time (70+) compositions.
- the methodology consisted of assessing transsepidermal water loss from the skin following a partial removal of the horny extract at baseline and after 7, 14, and 28 days of use of the composition.
- a tape-stripping process was used, where 30 repetitions of application and removal of transparent medical tape (Transpore 3M, 3M, Brazil) were performed in demarcated sites on the forearm, followed by measuring transsepidermal water loss (Tewameter® 300 and Multiprobe Adapter MPA-5, CKeletronics, Germany).
- the forearms of composition and control application were randomized. Since a forearm, identified with a satin bracelet, was used for the application of the composition, while the other forearm remained as control (no application of any products).
- the composition applied to the skin of the volar forearm conferred significant skin barrier fortification effect when compared to the control after 7, 14 and 28 days of home use.
- the percentage value obtained from skin barrier fortification in relation to initial skin condition and control was 13.0% after 7 days, 18.6% after 14 days and 27.9% after 28 days of home use. 84.6% of the research participants presented fortification of the skin barrier after home use of the composition.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112018074202-3A BR112018074202B1 (pt) | 2016-05-24 | 2017-05-24 | Composição cosmética antissinais, kit de composições e método para tratamento cosmético da pele |
US16/304,530 US11478409B2 (en) | 2016-05-24 | 2017-05-24 | Anti-wrinkle cosmetic composition, composition system and method for cosmetic skin treatment |
MX2018014430A MX2018014430A (es) | 2016-05-24 | 2017-05-24 | Composicion cosmetica antienvejecimiento, sistema de composicion y metodo para tratamiento cosmetico de la piel. |
EP17801852.9A EP3466406A4 (en) | 2016-05-24 | 2017-05-24 | ANTI-WRINKLE COSMETIC, COMPOSITION AND METHOD FOR THE COSMETIC TREATMENT OF THE SKIN |
US17/932,547 US20230000735A1 (en) | 2016-05-24 | 2022-09-15 | Anti-wrinkle cosmetic composition, composition system and method for cosmetic skin treatment |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102016021328-2 | 2016-05-24 | ||
BR102016011784-4A BR102016011784B1 (pt) | 2016-05-24 | 2016-05-24 | Composição cosmética antissinais e sistema de composições |
BR102016011785-2A BR102016011785B1 (pt) | 2016-05-24 | 2016-05-24 | Composição cosmética antissinais e sistema de composições |
BR102016011785-2 | 2016-05-24 | ||
BR102016011793-3 | 2016-05-24 | ||
BR102016011784-4 | 2016-05-24 | ||
BR102016011793-3A BR102016011793B1 (pt) | 2016-05-24 | 2016-05-24 | Composição cosmética antissinais e sistema de composições |
BR102016021328-2A BR102016021328B1 (pt) | 2016-09-15 | 2016-09-15 | Composição cosmética antissinais e sistema de composições |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/304,530 A-371-Of-International US11478409B2 (en) | 2016-05-24 | 2017-05-24 | Anti-wrinkle cosmetic composition, composition system and method for cosmetic skin treatment |
US17/932,547 Division US20230000735A1 (en) | 2016-05-24 | 2022-09-15 | Anti-wrinkle cosmetic composition, composition system and method for cosmetic skin treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017201596A1 true WO2017201596A1 (pt) | 2017-11-30 |
Family
ID=60411001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2017/050127 WO2017201596A1 (pt) | 2016-05-24 | 2017-05-24 | Composição cosmética antissinais, sistema de composições e método para tratamento cosmético da pele |
Country Status (5)
Country | Link |
---|---|
US (2) | US11478409B2 (pt) |
BR (1) | BR112018074202B1 (pt) |
CL (1) | CL2018003353A1 (pt) |
MX (3) | MX2018014430A (pt) |
WO (1) | WO2017201596A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2022349643A1 (en) * | 2021-09-23 | 2024-04-04 | Edgewell Personal Care Brands, Llc | Personal care compositions having enhanced antioxidant performance |
CN113893203B (zh) * | 2021-11-23 | 2023-06-20 | 湖北省麦诗特生物科技有限公司 | 一种含有抗衰老功效脂质体的面霜组合物及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003055190A (ja) * | 2001-08-07 | 2003-02-26 | Koei Kogyo Kk | コラゲナーゼ阻害剤及び抗老化用化粧料 |
WO2015031971A2 (en) * | 2013-09-09 | 2015-03-12 | Natura Cosméticos S.A. | A composition comprising guaçatonga extract and aroeira extract/ use thereof and a method for preventing and/or treating signals caused by skin aging |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4880816B2 (ja) * | 2000-12-15 | 2012-02-22 | 株式会社ヤクルト本社 | 皮膚老化防止剤 |
US20050124705A1 (en) * | 2002-03-28 | 2005-06-09 | Beiersdorf Ag | Cosmetic or pharmaceutical, low-viscosity oil-in-water emulsions containing phospholipids |
US20050276833A1 (en) * | 2004-06-14 | 2005-12-15 | Schering Plough Healthcare Products, Inc. | Skincare compositions |
WO2007029982A1 (en) * | 2005-09-08 | 2007-03-15 | Amorepacific Corporation | Composition of skin external application for anti-aging |
BRPI0503875A (pt) | 2005-09-26 | 2007-06-12 | Natura Cosmeticos Sa | composição cosmética multifuncional, processo para preparar a referida composição cosmética e produto cosmético |
WO2008079898A1 (en) | 2006-12-20 | 2008-07-03 | Pharmwest, Inc. | Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions |
CA2752389C (en) * | 2009-02-13 | 2017-01-03 | Peplin Research Pty Ltd | Use of ingenols in the treatment of aged skin |
EP2228052A1 (en) * | 2009-03-09 | 2010-09-15 | Coty Deutschland GmbH | Cosmetic basic composition and use thereof |
FR2949684B1 (fr) * | 2009-09-04 | 2011-12-16 | Silab Sa | Principe actif issu de candida saitoana et utilisation cosmetique pour la detoxification des cellules de la peau |
US20110305737A1 (en) | 2010-06-09 | 2011-12-15 | NY Derm LLC | Multi-Active Microtargeted Anti-Aging Skin Cream Polymer Technology |
US20110305735A1 (en) * | 2010-06-09 | 2011-12-15 | Lipotec, S.A. | Skin antiaging treatment |
US8747817B1 (en) * | 2010-12-02 | 2014-06-10 | William Scott Prendergast | System and method of complementary day/night children's skin cream compositions |
KR20140134712A (ko) | 2012-03-22 | 2014-11-24 | 프리시전 더마톨로지, 인크. | 시클로덱스트린 기재의 마이크로에멀젼 및 그의 피부과용 용도 |
CN105209125A (zh) | 2013-05-16 | 2015-12-30 | 帝斯曼知识产权资产管理有限公司 | 包含天然有机油和聚甲基丙烯酸甲酯颗粒的化妆品组合物 |
US20150202139A1 (en) * | 2014-01-21 | 2015-07-23 | Md Solarciences Corp. | Anti-aging skincare products |
ES2814552T3 (es) * | 2014-10-31 | 2021-03-29 | Lipotec S A U | Composición cosmética y/o farmacéutica que contiene un producto extracelular bacteriano de la Pseudoalteromonas antarctica y su uso |
-
2017
- 2017-05-24 WO PCT/BR2017/050127 patent/WO2017201596A1/pt active Search and Examination
- 2017-05-24 MX MX2018014430A patent/MX2018014430A/es unknown
- 2017-05-24 US US16/304,530 patent/US11478409B2/en active Active
- 2017-05-24 BR BR112018074202-3A patent/BR112018074202B1/pt active Search and Examination
-
2018
- 2018-11-23 CL CL2018003353A patent/CL2018003353A1/es unknown
- 2018-11-23 MX MX2022006927A patent/MX2022006927A/es unknown
- 2018-11-23 MX MX2022006928A patent/MX2022006928A/es unknown
-
2022
- 2022-09-15 US US17/932,547 patent/US20230000735A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003055190A (ja) * | 2001-08-07 | 2003-02-26 | Koei Kogyo Kk | コラゲナーゼ阻害剤及び抗老化用化粧料 |
WO2015031971A2 (en) * | 2013-09-09 | 2015-03-12 | Natura Cosméticos S.A. | A composition comprising guaçatonga extract and aroeira extract/ use thereof and a method for preventing and/or treating signals caused by skin aging |
Also Published As
Publication number | Publication date |
---|---|
MX2018014430A (es) | 2019-04-01 |
BR112018074202A2 (pt) | 2019-03-06 |
US11478409B2 (en) | 2022-10-25 |
MX2022006928A (es) | 2022-07-12 |
MX2022006927A (es) | 2022-07-12 |
CL2018003353A1 (es) | 2019-05-03 |
BR112018074202B1 (pt) | 2022-08-02 |
US20190167540A1 (en) | 2019-06-06 |
US20230000735A1 (en) | 2023-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6789263B2 (ja) | 皮膚の保護に使用するための化合物 | |
US10285932B2 (en) | Skin care formulations | |
JP4729343B2 (ja) | 敏感肌又は不耐性皮膚の許容限界を増大させるための少なくとも一のキレート剤を含む組成物の使用 | |
US20230000735A1 (en) | Anti-wrinkle cosmetic composition, composition system and method for cosmetic skin treatment | |
JP2012041302A (ja) | 皮膚化粧料 | |
WO2018112586A1 (pt) | Composição cosmética de maquiagem, base líquida e uso de uma composição cosmética de maquiagem | |
US20100173027A1 (en) | O/w emulsion for hand care | |
KR20160141297A (ko) | 피부 탄력에 효과를 갖는 마유를 함유하는 피부 재생용 화장료 조성물 및 이의 제조방법 | |
EP3466406A1 (en) | Anti-wrinkle cosmetic composition, composition system and method for cosmetic skin treatment | |
KR20220021507A (ko) | 안면부 피부 보습 및 붓기 완화용 화장료 조성물 | |
KR20190040426A (ko) | 두피노화 예방 및 완화, 및 탈모방지 효과가 있는 화장료 조성물 | |
JP2017193506A (ja) | 皮膚化粧料 | |
US20190224110A1 (en) | Cosmetic anti-blemish composition, use of the composition, anti-blemish treatment method and application device | |
EP2253304B1 (en) | Nifedipine-based compositions for anti-wrinkle treatments | |
US11071695B2 (en) | Cosmetic anti-blemish composition, use of the composition and anti-blemish treatment method | |
BR102016011785A2 (pt) | Anti-success cosmetic composition and composition system | |
BR102016011784A2 (pt) | Anti-success cosmetic composition and composition system | |
BR112018074893B1 (pt) | Composição cosmética antissinais, uso da composição e dispositivo de aplicação | |
BR102016011793B1 (pt) | Composição cosmética antissinais e sistema de composições | |
BR102016021328A2 (pt) | Composição cosmética antissinais e sistema de composições | |
Somwanshi et al. | Cosmetic Science | |
US20120156147A1 (en) | Cosmetic composition; skin treatment kit; method for treating oily or mixed skin or acned skin | |
CN117942279A (zh) | 包括神经酰胺和鞘脂的化妆品组合物 | |
Tanuwidjaja | Development of Anti-Aging Cream Preparations with Active Substances from Plant Extracts: Physicochemical Review and Potential Applications | |
WO2013143866A2 (de) | Kosmetische und dermatologische zubereitungen, enthaltend eine oder mehrere substanzen, die das gen für den "krüppel-like factor 9" (klf9) modulieren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17801852 Country of ref document: EP Kind code of ref document: A1 |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112018074202 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2017801852 Country of ref document: EP Effective date: 20190102 |
|
ENP | Entry into the national phase |
Ref document number: 112018074202 Country of ref document: BR Kind code of ref document: A2 Effective date: 20181123 |